Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer
暂无分享,去创建一个
I. Zlobec | D. Inderbitzin | V. Koelzer | A. Lugli | M. D. Berger | H. Dawson | G. Rieger | M. Hädrich | Marion Hädrich
[1] Phil Quirke,et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 , 2017, Modern Pathology.
[2] A. Rogers,et al. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer , 2016, British Journal of Cancer.
[3] Inti Zlobec,et al. Tumor budding in colorectal cancer--ready for diagnostic practice? , 2016, Human pathology.
[4] F. Offner,et al. Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study , 2015, Virchows Archiv.
[5] M. Borner,et al. Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients , 2013, British Journal of Cancer.
[6] S. Gurzu,et al. Possible neuroendocrine phenotype of poorly differentiated cell clusters in colorectal carcinoma, as a prognostic parameter. , 2014, The American journal of surgical pathology.
[7] A. Rogers,et al. Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy , 2014, Modern Pathology.
[8] A. Radcliffe,et al. Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[9] N. Ordóñez. Broad-spectrum immunohistochemical epithelial markers: a review. , 2013, Human pathology.
[10] L. Terracciano,et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. , 2013, Human pathology.
[11] E. Patsouris,et al. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer , 2013, Modern Pathology.
[12] D. Kerr,et al. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer , 2013, The Journal of pathology.
[13] G. Petris,et al. Tumor Budding in Colorectal Carcinoma: Time to Take Notice , 2013 .
[14] R. Riddell,et al. Tumor budding in colorectal carcinoma: time to take notice , 2012, Modern Pathology.
[15] K. Chayama,et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection , 2012, Journal of gastroenterology and hepatology.
[16] S. Gurzu,et al. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations. , 2012, Pathology, research and practice.
[17] J. O’Sullivan,et al. Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein Status , 2011, International Journal of Surgical Pathology.
[18] Tadakazu Shimoda,et al. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma , 2010, Modern Pathology.
[19] L. Terracciano,et al. CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer , 2009, British Journal of Cancer.
[20] Seung-Yong Jeong,et al. Indications for Subsequent Surgery After Endoscopic Resection of Submucosally Invasive Colorectal Carcinomas: A Prospective Cohort Study , 2009, Diseases of the colon and rectum.
[21] J. O’Sullivan,et al. Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.
[22] H. Mitomi,et al. Tumor Budding as an Index to Identify High-Risk Patients with Stage II Colon Cancer , 2008, Diseases of the colon and rectum.
[23] F. Prall. Tumour budding in colorectal carcinoma , 2007, Histopathology.
[24] Hidetaka Mochizuki,et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.
[25] H. Ueno,et al. Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer , 2002, Histopathology.
[26] M. Morimatsu,et al. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.
[27] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.